Healthcare Industry News: Stent-Graft
News Release - August 12, 2009
Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction DeviceCardioVasc Advantage(TM) Vascular Reconstruction Device now cleared for marketing in Europe
PALO ALTO, Calif., Aug. 12 -- (Healthcare Sales & Marketing Network) -- Nfocus Neuromedical Inc. announced today that its CardioVasc Advantage(TM) Vascular Reconstruction Device has been granted CE Mark approval by the European Notified Body, G-Med.
The CardioVasc Advantage(TM) Vascular Reconstruction Device has been cleared in Europe for the treatment of coronary artery perforations, aneurysms and saphenous vein graft lesions. Today, these critical pathologies are most frequently treated through less-invasive endovascular procedures. The Advantage VRD was designed to provide clinical benefits in these exacting procedures performed in small vessels.
"The Advantage VRD is a significant advance over previous small-vessel Stent-Grafts," said Martin S. Dieck, President and CEO.
"The Advantage VRD has greatly improved flexibility and a smaller crossing profile when compared to competitive devices. The European CE Mark approval gives Nfocus the ability to market this advanced system for the treatment of serious coronary vascular indications. The device is capable of attaining more distal placement with less vessel trauma due to its innovative design."
About Nfocus Neuromedical, Inc.
Nfocus is positioning itself to be the world-wide leader in the development of next-generation endovascular neurosurgery solutions (surgery through less-invasive catheter devices) . Backed by premier venture investors, the Company's primary mission is developing revolutionary systems to treat neurovascular disease, including brain aneurysms, that are simple, safe, cost-effective and curative.
To learn more about the Nfocus Neuromedical development programs focused on providing faster, simpler and more permanent treatment of vascular diseases of the brain and spine, please visit the Nfocus website: www.nfocusneuro.com.
For more information about aneurysms and hemorrhagic stroke see: www.strokeassociation.org and www.snisonline.org
Source: Nfocus Neuromedical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.